REVB Revelation Biosciences reports vastly wider Q4 2025 loss than estimates shares end flat for the trading day Enliven Therapeutics ELVN Stock Industry Opportunities 082 20260427 MaxCyte MXCT Stock ShortTerm Trend Technical Strength 20260427